Ryan Megan, Ryznar Rebecca
College of Osteopathic Medicine, Rocky Vista University, Parker, CO, United States.
Molecular Biology, Department of Biomedical Sciences, Rocky Vista University, Parker, CO, United States.
Front Psychiatry. 2022 May 6;13:856998. doi: 10.3389/fpsyt.2022.856998. eCollection 2022.
Resilience refers to the adaptability of a person - an ability to "bounce-back" from stressors. We question if resilience can be strengthened, potentially to decrease the risk of stress-related disorders. Unfortunately, the molecular origins of resilience are complicated and not yet well understood. In this review, we examine the various physiological biomarkers of resilience, including the associated genes, epigenetic changes, and protein biomarkers associated with resilient phenotypes. In addition to assessing biomarkers that may indicate higher levels of resilience, we also review at length the many biomarkers that confer lower levels of resilience and may lead to disorders of low resilience, such as anxiety and depression. This large and encompassing review may help to identify the possible therapeutic targets of resilience. Hopefully these studies will lead to a future where stress-related disorders can be prevented, rather than treated.
复原力指的是一个人的适应能力——即从压力源中“恢复过来”的能力。我们质疑复原力是否可以得到增强,从而有可能降低与压力相关疾病的风险。不幸的是,复原力的分子起源很复杂,尚未得到充分理解。在这篇综述中,我们研究了复原力的各种生理生物标志物,包括相关基因、表观遗传变化以及与复原力表型相关的蛋白质生物标志物。除了评估可能表明更高复原力水平的生物标志物外,我们还详细回顾了许多导致较低复原力水平并可能导致低复原力相关疾病(如焦虑和抑郁)的生物标志物。这篇全面的综述可能有助于确定复原力可能的治疗靶点。希望这些研究能引领未来预防而非治疗与压力相关疾病的方向。